Nutex Health Cash Flow Statement
NASDAQ: NUTXConsumer DiscretionaryBusiness ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Nutex Health free cash flow
In fiscal 2025, Nutex Health generated $248.1 million of operating cash flow and spent $2.5 million on capital expenditures. That left free cash flow of $245.6 million, a free-cash-flow margin of 28.1% of revenue. Free cash flow was up 1078.0% from the prior year's $20.8 million.
Nutex Health returned $5.0 million to shareholders through share repurchases, equal to 2% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Nutex Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 180.36M | 94.81M | -43.42M | -432.74M | 168.53M | 145.56M | -7.12M | -950.13K | 582.06K | -7.43M |
| Net Income growth (YoY) | +90.24% | — | — | -356.78% | +15.78% | — | — | -263.24% | — | -8968.07% |
| Depreciation & Amortization | 20.53M | 18.97M | 17.59M | 13.13M | 7.66M | 5.90M | 156.09K | 2.69K | 1.14K | 473 |
| Stock-Based Compensation | 107.78M | -129.74K | — | 189.58K | 4.03M | 2.57M | 450.05K | 155.89K | 924.33K | 1.50K |
| Change in Working Capital | -14.63M | -189.12M | -6.36M | 64.50M | -7.98M | -72.26M | -72.89K | 320.03K | 62.76K | 67.07K |
| Operating Cash Flow | 248.13M | 23.15M | 1.26M | 50.61M | 173.43M | 86.67M | -4.04M | -480.05K | -714.62K | -274.22K |
| Capital Expenditures | -2.53M | -2.30M | -9.50M | -14.63M | -36.93M | -61.19M | -84.00K | 0 | — | — |
| Investing Cash Flow | -5.24M | -5.61M | -11.24M | -4.34M | -36.98M | -61.19M | -748.20K | -116.96K | 2.05K | -9.99K |
| Share Repurchases | -5.00M | 0 | 0 | — | — | — | — | — | — | — |
| Debt Issued | — | — | — | — | — | — | — | 709.50K | 469.00K | 50.00K |
| Debt Repaid | — | -4.63M | -3.48M | -1.72M | -1.26M | -1.55M | — | — | — | — |
| Financing Cash Flow | -97.95M | 1.09M | -2.27M | -48.13M | -125.85M | -7.97M | 5.73M | 704.57K | 711.50K | 172.44K |
| Net Change in Cash | 144.93M | 18.64M | -12.25M | -1.86M | 10.60M | -1.04M | 946.17K | 107.56K | -1.07K | -111.77K |
| Free Cash Flow | 245.60M | 20.85M | -8.24M | 35.97M | 136.51M | 25.48M | -4.12M | -480.05K | -714.62K | -274.22K |
This table shows 10 annual periods of Nutex Health's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow NUTX's reporting calendar. What is a cash flow statement?